Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Clinical trial NCT06312644 · RECRUITING

Trial details

NCT number: NCT06312644
Sponsor: Alexion Pharmaceuticals, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Ultomiris-exposed Pregnant/ Postpartum Pregnancy Paroxysmal Nocturnal Hemoglobinuria (PNH)Atypical Hemolytic Uremic Syndrome (aHUS)Generalized Myasthenia Gravis (gMG)Neuromyelitis Optica Spectrum Disorder (NMOSD)

Start date: 2024-12-16
Primary completion: 2034-07-11
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.